de Langen AJ, Johnson ML, Mazieres J, Dingemans AC, et al. Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRAS(G12C) mutation: a randomised, open-label, phase 3 trial. Lancet 2023 Feb 7:S0140-6736(23)00221-0. doi: 10.1016/S0140-6736(23)00221.
PMID: 36764316